BUY Krishna Institute of Medical Sciences Limited — Kunal Bothra
byKunal BothraHorizon: NA (inferred Swing (≤2wk))10 Jul 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
सन फार्माच्या डीलमुळे भारतीय फार्मा सेक्टरमध्ये ₹13.9 बिलियनचा व्यवहार; विशेष पोर्टफोलिओवर भर
NewsGoogle News·23 Jul · today
Indian Pharma Q1 FY27 Deals: సన్ ఫార్మా అద్భుతంతో **$13.9 బిలియన్** విలువ నమోదు
NewsGoogle News·23 Jul · today
2 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·9 Jul · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Krishna Institute of Medical Sciences
- BUY — Jigar S Patel, Anand Rathi19 Oct 2026 · ~3 months · target ₹800 · Active
- BUY — HSBC Securities9 Oct 2026 · ~1 year · target ₹865 · Active
- BUY — Goldman Sachs1 Oct 2026 · ~1 year · target ₹1,000 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹850 · Active
- BUY — Rakesh Bansal24 Sept 2026 · ~2 weeks · target ₹831 · SL hit
More from Kunal Bothra
- BUY Ambuja Cements22 Oct 2026 · ~2 weeks · target ₹388 · Active
- BUY Biocon22 Oct 2026 · ~2 weeks · target ₹345 · Active
- BUY Tata Consultancy Services22 Oct 2026 · ~2 weeks · target ₹2,630 · Active
- SELL Oberoi Realty22 Oct 2026 · Same day · target ₹1,600 · Expired
- BUY HCL Technologies22 Oct 2026 · ~2 weeks · target ₹1,468 · Active

